(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.95%) $83.05
(-1.16%) $1.619
(-0.29%) $2 340.40
(-0.07%) $27.52
(0.50%) $926.70
(-0.15%) $0.933
(-0.15%) $11.01
(-0.23%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally...
Stats | |
---|---|
今日成交量 | 266 157 |
平均成交量 | 184 103 |
市值 | 1.79B |
EPS | €0 ( 2024-02-18 ) |
下一个收益日期 | ( €0 ) 2024-05-12 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -42.85 |
ATR14 | €0.00700 (0.08%) |
音量 相关性
Almirall, S.A. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Almirall, S.A. 相关性 - 货币/商品
Almirall, S.A. 财务报表
Annual | 2023 |
营收: | €898.80M |
毛利润: | €581.40M (64.69 %) |
EPS: | €-0.200 |
FY | 2023 |
营收: | €898.80M |
毛利润: | €581.40M (64.69 %) |
EPS: | €-0.200 |
FY | 2022 |
营收: | €863.25M |
毛利润: | €680.78M (78.86 %) |
EPS: | €0.0237 |
FY | 2021 |
营收: | €827.20M |
毛利润: | €655.61M (79.26 %) |
EPS: | €-0.233 |
Financial Reports:
No articles found.
Almirall, S.A.
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。